Cognition Therapeutics

+$0.13 (+1.04%) As of 2:23 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGTX and other ETFs, options, and stocks.

About CGTX

Cognition Therapeutics, Inc. is a clinical stage neuroscience company. The firm develops drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders.

CEO
Lisa R. Ricciardi
Employees
22
Headquarters
Purchase, New York
Founded
2007

CGTX Key Statistics

Market Cap
259.13M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
554.28K
High Today
$12.13
Low Today
$12.00
Open Price
$12.00
Volume
7.66K
52 Week High
$13.80
52 Week Low
$11.90

CGTX Earnings

Q3 FY21
Estimated
— per share
Actual
Expected Nov 1, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure